HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases

The aim of this study is to evaluate a new tumour marker, HE4, in comparison with CA 125 and the Risk of Ovarian Malignancy Algorithm (ROMA) in healthy women and in patients with benign and malignant gynaecological diseases. CA 125 and HE4 serum levels were determined in 66 healthy women, 285 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Molina, Rafael, Escudero, Jose M., Augé, Jose M., Filella, Xavier, Foj, Laura, Torné, Aureli, Lejarcegui, Jose, Pahisa, Jaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195682/
https://www.ncbi.nlm.nih.gov/pubmed/21863264
http://dx.doi.org/10.1007/s13277-011-0204-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195682/
https://www.ncbi.nlm.nih.gov/pubmed/21863264
http://dx.doi.org/10.1007/s13277-011-0204-3

Ejemplares similares